Back to hamad.qa
عربي
Staff login

Publications

2022

​
  1. Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections. Altarawneh HN, Chemaitelly H, Ayoub HH, Tang P, Hasan MR, Yassine HM, Al-Khatib, HA, Smatti MK, Coyle P, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif, AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ.N Engl J Med. 2022 Jul 7;387(1):21-34. doi: 10.1056/NEJMoa2203965. Epub 2022 Jun 15. PMID: 35704396.

  2. Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar. Abu-Raddad LJ, Chemaitelly H, Ayoub HH, AlMukdad S, Yassine HM, Al-Khatib HA, Smatti MK, Tang P, Hasan MR, Coyle P, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R. N Engl J Med. 2022 May12;386(19):1804-1816. doi: 10.1056/NEJMoa2200797. Epub 2022 Mar 9. PMID: 35263534

  3. Protection against the Omicron Variant from Previous SARS-CoV-2 Infection.Altarawneh HN,Chemaitelly H, Hasan MR, Ayoub HH, Qassim S, AlMukdad S, Coyle P, Yassine HM, Al-Khatib HA, Benslimane FM, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt, AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Tang P, Abu-Raddad LJ. N Engl J Med. 2022 Mar 31;386(13):1288-1290. https://doi.org/10.1056/nejmc2200133 Epub 2022 Feb 9. PMID: 35139269.

  4. Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections. Abu-Raddad LJ, Chemaitelly H, Ayoub HH, Tang P, Coyle P, Hasan MR, Yassine HM, Benslimane FM, Al-Khatib HA, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al- Romaihi HE, Al-Khal A, Al-Thani MH, Bertollini R.Nat Commun. 2022 Jan 27;13(1):532. doi: https://doi.org/10.1038/s41467-022-28199-7 .PMID: 35087035.

  5. Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage. Chemaitelly H, Ayoub HH, Coyle P, Tang P, Yassine HM, Al-Khatib HA, Smatti MK, Hasan MR, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik, RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Nat Commun. 2022 Aug 9;13(1):4675. doi: https://doi.org/10.1038/s41467-022-32363-4 PMID: 35945213.

  6. Duration of immune protection of SARS-CoV-2 natural infection against reinfection. Chemaitelly, H., Nagelkerke, N., Ayoub, H. H., Coyle, P., Tang, P., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Hasan, M. R., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G. K., Al-Kuwari, M. G., Butt, A. A., Al-Romaihi, H. E., … Abu-Raddad, L. J. (2022). Journal of travel medicine, 29(8), taac109. https://doi.org/10.1093/jtm/taac109

  7. Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar. Chemaitelly H, Ayoub HH, AlMukdad S, Coyle P, Tang P, Yassine HM, Al-Khatib HA, Smatti MK, Hasan MR, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Nat Commun. 2022 Jun2;13(1):3082. doi: https://doi.org/10.1038/s41467-022-30895-3 PMID: 35654888.

  8. Effects of BA.1/BA.2 subvariant, vaccination and prior infection on infectiousness of SARS-CoV-2 omicron infections. Qassim, S. H., Chemaitelly, H., Ayoub, H. H., AlMukdad, S., Tang, P., Hasan, M. R., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Abdul-Rahim, H. F., Nasrallah, G. K., Al-Kuwari, M. G., Al-Khal, A., Coyle, P., Kaleeckal, A. H., Shaik, R. M., Latif, A. N., Al-Kuwari, E., Jeremijenko, A., Butt, A. A., … Abu-Raddad, L. J. (2022). Journal of travel medicine, 29(6), taac068. https://doi.org/10.1093/jtm/taac068

  9. Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants. Altarawneh HN, Chemaitelly H, Ayoub HH, Hasan MR, Coyle P, Yassine HM, Al-Khatib HA, Smatti MK, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-RomaihiHE, Al-Thani MH, Al-Khal A, Bertollini R, Tang P, Abu-Raddad LJ. N Engl J Med. 2022 Oct 5. doi: 10.1056/NEJMc2209306.

  10. Alsaed, O., Al Emadi, S., Satti, E., Muthanna, B., Akkam Veettil, S. F., Ashour, H., Chandra, P., Alkuwari, E. A., & Coyle, P. (2022). Humoral Response of Patients With Autoimmune Rheumatic Disease to BNT162b2 Vaccine: A Retrospective Comparative Study. Alsaed, O., Al Emadi, S., Satti, E., Muthanna, B., Akkam Veettil, S. F., Ashour, H., Chandra, P., Alkuwari, E. A., & Coyle, P. (2022). Cureus, 14(4), e24585. https://doi.org/10.7759/cureus.24585

  11. Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections. Qassim, S. H., Hasan, M. R., Tang, P., Chemaitelly, H., Ayoub, H. H., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Abdul-Rahim, H. F., Nasrallah, G. K., Al-Kuwari, M. G., Al-Khal, A., Coyle, P., Gillani, I., Kaleeckal, A. H., Shaik, R. M., Latif, A. N., Al-Kuwari, E., Jeremijenko, A., Butt, A. A., … Abu-Raddad, L. J. (2022). Frontiers in immunology, 13, 984784. https://doi.org/10.3389/fimmu.2022.984784

  12. Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2. Chemaitelly, H., Ayoub, H. H., Tang, P., Hasan, M. R., Coyle, P., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G. K., Al-Kuwari, M. G., Butt, A. A., Al-Romaihi, H. E., Al-Thani, M. H., … Abu-Raddad, L. J. (2022). The New England journal of medicine, 387(18), 1716–1718. https://doi.org/10.1056/NEJMc2211055

  13. Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study. Chemaitelly, H., Ayoub, H. H., AlMukdad, S., Coyle, P., Tang, P., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Hasan, M. R., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G. K., Al-Kuwari, M. G., Butt, A. A., Al-Romaihi, H. E., … Abu-Raddad, L. J. (2022). The Lancet. Microbe, 3(12), e944–e955. https://doi.org/10.1016/S2666-5247(22)00287-7

  14. Covid-19 Vaccine Protection among Children and Adolescents in Qatar. Chemaitelly, H., AlMukdad, S., Ayoub, H. H., Altarawneh, H. N., Coyle, P., Tang, P., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Hasan, M. R., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G. K., Al-Kuwari, M. G., Al-Romaihi, H. E., … Abu-Raddad, L. J. (2022). The New England journal of medicine, 387(20), 1865–1876. https://doi.org/10.1056/NEJMoa2210058

  15. Functional Characterization of the MYO6 Variant p.E60Q in Non-Syndromic Hearing Loss Patients. Alkowari, M., Espino-Guarch, M., Daas, S., Abdelrahman, D., Hasan, W., Krishnamoorthy, N., Sathappan, A., et al. (2022). International Journal of Molecular Sciences, 23(6), 3369. MDPI AG. Retrieved from http://dx.doi.org/10.3390/ijms23063369

  16. Asthma and the Missing Heritability Problem: Necessity for Multiomics Approaches in Determining Accurate Risk Profiles. Augustine T, Al-Aghbar MA, Al-Kowari M, Espino-Guarch M and van Panhuys N (2022). Front. Immunol. 13:822324. https://doi.org/10.3389/fimmu.2022.822324

  17. Primary Hepatic Epithelioid Hemangioendothelioma Masquerading as a Hepatic Abscess With Infective Picture: A Case Report. Kolleri JJ, Khaliq A, Ladumor SB, Habtezghi AB, Koshy SM, Petkar M. Cureus. 2022 Mar 5;14(3):e22859. doi: 10.7759/cureus.22859. eCollection 2022 Mar. PMID: 35392441

  18. Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review. Ahmed A, Ata F, Gaber M, Petkar M, Mahfouz A, Schirmacher P, Musa S, Hashim A. Curr Probl Cancer. 2022 Jun;46(3):100847. doi: 10.1016/j.currproblcancer.2022.100847. Epub 2022 Mar 2. PMID: 35276469

  19. Time equals sight: Sphenoid sinus aspergilloma with vision loss. Ali GA, Al Maslamani M, Petkar M, Ammar A, Goravey W. IDCases. 2022 Feb 1;27:e01440. doi: 10.1016/j.idcr.2022.e01440. eCollection 2022. PMID: 35169543

  20. Sausage digit: Isolated tuberculous tenosynovitis of the middle finger. Goravey W, Al Maslamani M, Petkar M, Ammar A, Ali GA. IDCases. 2022 Feb 1;27:e01438. doi: 10.1016/j.idcr.2022.e01438. eCollection 2022. PMID: 35169542

  21. What you see might not be what you get: Analysis of 15 prospective cases of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Al Hassan MS, El Ansari W, El Baba H, Petkar M, Abdelaal A. Int J Surg Case Rep. 2022 Feb;91:106751. doi: 10.1016/j.ijscr.2021.106751. Epub 2022 Jan 5. PMID: 35134690

  22. Uterine Adenosarcoma with Sarcomatous Overgrowth and Rhabdoid Features: A Rare Case. Rashid S , Akhtar M. Saudi J Med Med Sci. 2022. PMID: 35283707

  23. The Many Faces of Serous Neoplasms and Related Lesions of the Female Pelvis: A Review. Rashid S, Arafah MA, Akhtar M. Adv Anat Pathol. 2022. PMID: 3518073

  24. Prevalence and microbiological and genetic characteristics of multidrug-resistant Pseudomonas aeruginosa over three years in Qatar. Sid Ahmed, M., Abdel Hadi, H., Abu Jarir, S., Ahmad Khan, F., Arbab, M., Hamid, J., . . . Ziglam, H. (2022). Antimicrobial Stewardship & Healthcare Epidemiology, 2(1), E96. doi:10.1017/ash.2022.226

  25. Association of blaVIM-2, blaPDC-35, blaOXA-10, blaOXA-488 and blaVEB-9 β-Lactamase Genes with Resistance to Ceftazidime–Avibactam and Ceftolozane–Tazobactam in Multidrug-Resistant Pseudomonas aeruginosa. Sid Ahmed MA, Khan FA, Hadi HA, Skariah S, Sultan AA, Salam A, Al Khal AL, Söderquist B, Ibrahim EB, Omrani AS, Jass J. Antibiotics. 2022; 11(2):130. https://doi.org/10.3390/antibiotics11020130

  26. Correlations between Circulating and Tumor-Infiltrating CD4+ T Cell Subsets with Immune Checkpoints in Colorectal Cancer. Al-Mterin MA, Murshed K, Elkord E.Vaccines (Basel). 2022 Mar 30;10(4):538. doi: 10.3390/vaccines10040538.PMID: 35455287

  27. Associations of Complete Blood Count Parameters with Disease-Free Survival in Right- and Left-Sided Colorectal Cancer Patients. Alsalman A, Al-Mterin MA, Abu-Dayeh A, Alloush F, Murshed K, Elkord E.J Pers Med. 2022 May 18;12(5):816. doi: 10.3390/jpm12050816.PMID: 35629238

  28. Associations of different immune checkpoints-expressing CD4+ Treg/ T cell subsets with disease-free survival in colorectal cancer patients. Al-Mterin MA, Murshed K, Alsalman A, Abu-Dayeh A, Elkord E.BMC Cancer. 2022 Jun 2;22(1):601. doi: 10.1186/s12885-022-09710-1.PMID: 35655158

  29. A case of thyroid carcinoma with mucinous features harboring ETV6-NTRK3 fusion: Expanding the morphologic spectrum of NTRK-rearranged thyroid carcinoma. Khaled A. Murshed, Ala Abu-Dayeh, Wafa Abualainin, Mahir Petkar. (2022) Human Pathology Reports, Volume 28 https://doi.org/10.1016/j.hpr.2022.300623

  30. Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8+ Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients. Alsalman A, Al-Mterin MA, Murshed K, Alloush F, Al-Shouli ST, Toor SM, Elkord E. Cancers. 2022; 14(13):3194. https://doi.org/10.3390/cancers14133194

  31. Concurrent Presentation of Hairy Cell Leukemia and Mantle Cell Lymphoma (Leukemic Non-Nodal Variant): An Extremely Rare Composite Lymphoma. Soliman DS, Ibrahim F, Fernyhough LJ, Murad F, Akiki S.J Hematol. 2022 Feb;11(1):21-28. doi: 10.14740/jh942. Epub 2022 Jan 10. PMID: 35356636 Free PMC article.

  32. Qatar genome: Insights on genomics from the Middle East.Mbarek H, Devadoss Gandhi G, Selvaraj S, Al-Muftah W, Badji R, Al-Sarraj Y, Saad C, Darwish D, Alvi M, Fadl T, Yasin H, Alkuwari F, Razali R, Aamer W, Abbaszadeh F, Ahmed I, Mokrab Y, Suhre K, Albagha O, Fakhro K, Badii R, Ismail SI, Althani A; Qatar Genome Program Research Consortium.Hum Mutat. 2022 Apr;43(4):499-510. doi: 10.1002/humu.24336. Epub 2022 Feb 20.PMID: 35112413



Hamad Medical Corporation

HMC is the principal public healthcare provider in the State of Qatar, delivering the safest, most effective and most compassionate care to each and every one of our patients.

Latest Facebook Posts

Latest Twitter Posts

Privacy Notice. © Copyright - Hamad Medical Corporation by Corporate Communications Dept.
Top